ET
ALNY icon

Entropy Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History

Entropy Technologies’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
41,204
+5,485
+15% +$1.65M 0.49% 42
2026
Q1 		$11.8M Buy
35,719
+19,622
+122% +$6.68M 0.55% 40
2025
Q4 		$6.4M Sell
16,097
-1,084
-6% -$480K 0.35% 74
2025
Q3 		$7.83M Buy
17,181
+16,081
+1,462% +$6.55M 0.59% 29
2025
Q2 		$359K Buy
+1,100
New +$304K 0.03% 565
2024
Q3 		– Sell
-6,849
Closed -$1.66M – 705
2024
Q2 		$1.66M Buy
+6,849
New +$1.08M 0.18% 164

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Entropy Technologies's ALNY Position: Q2 2026 in Review

Entropy Technologies increased its Alnylam Pharmaceuticals (ALNY) stake by 15% in Q2 2026, buying an estimated $1.65M and bringing the position to 41,204 shares worth $12.4M. The position accounts for 0.49% of the portfolio, ranked #42.

Entropy Technologies first reported a position in ALNY in Q2 2024 and has held it in 6 quarters since. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Entropy Technologies held 41,204 shares of Alnylam Pharmaceuticals worth $12.4M as of Q2 2026.
  • Entropy Technologies bought 5,485 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.65M.
  • Alnylam Pharmaceuticals made up 0.49% of Entropy Technologies's portfolio in Q2 2026, its #42 holding.
  • Entropy Technologies first reported a position in Alnylam Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.